Dr. Sarah LeBoeuf is a postdoctoral researcher in the department of Pathology at the NYU School of Medicine. She is a member of the Papagiannakopoulos Lab, where she uses genetically engineered mouse models to study the role of mitochondria and reactive oxygen species stress in the development and progression of lung cancer. Among the goals of Dr. LeBoeuf's research is to elucidate the metabolic rewiring of cancer cells of specific genetic backgrounds so that they can be targeted therapeutically with small molecule drugs. For more information, visit the Papagiannakopoulos Lab web page.